Clinical Trial Update: The Efficiency of MSC in Refractory Crohn's Disease [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update on mesenchymal stem cell therapy for refractory Crohn's disease spanning Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Mesenchymal Stem Cells (MSC) (mesenchymal stem cells)

Snippet

Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University | Conditions: Crohn's Disease | Phase 2, Phase 3 | Status: UNKNOWN